HIV infection may potentiate specific biomarkers that influence the development of premature clinical indices commonly associated with aging. Therefore, predicting mortality outcomes in people living with HIV is extremely important as this population ages. This chapter describes biomarkers associated with inflammation, coagulation, and immune activation in HIV, and reviews the association between specific biomarkers and the development of co-morbid conditions in individuals with HIV. Measures that incorporate specific biomarkers related to HIV infection, designed to predict mortality outcomes in individuals with HIV, are also discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1159/000448543 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!